Neuroprotective Effects of the Purine-Derived Compound ITH15004 Against Nigericin- and Mitochondria-Induced Toxicity in NSC-34 Motor Neuron-like Cells

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive degeneration of motor neurons. Most patients die within 3 to 5 years of diagnosis, primarily due to respiratory failure, and effective therapeutic options remain limited. Mitochondrial dysfunction, oxidative stress, calcium dysregulation, and neuroinflammation are key contributors to ALS pathogenesis. In this study, we evaluated the potential neuroprotective effects of ITH15004, a novel compound with modulatory effects on P2X7 purinergic receptors, in an in vitro model using NSC-34 motor neuron-like cells. Cellular stress was induced using oligomycin (10 uM) and rotenone (30 uM), inhibitors of mitochondrial oxidative phosphorylation; nigericin (5 uM), a K+/H+ ionophore that disrupts ionic homeostasis; and extracellular ATP (1 mM), a purinergic receptor agonist. MTT-reducing activity was assessed as an indicator of cellular metabolic activity, while caspase-3/7 activity was measured to evaluate apoptotic responses. Intracellular ATP levels, cytosolic calcium responses, and cytochrome c and VDAC1 protein abundance were also analysed. ITH15004 significantly improved MTT-reducing activity following exposure to ATP, oligomycin/rotenone, and nigericin. In addition, ITH15004 partially restored intracellular ATP levels following nigericin treatment and significantly reduced nigericin-induced caspase-3/7 activation. Western blot analysis further revealed significant changes in cytochrome c and VDAC1 protein levels in response to ITH15004 treatment. These findings indicate that ITH15004 attenuates cellular damage induced by different stressors in NSC-34 cells and modulates several parameters associated with cellular energy status and apoptotic signalling. Further studies are needed to establish its mechanisms of action and assess its therapeutic potential in ALS.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-16
DOI
https://doi.org/10.64898/2026.11.13.766254
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Neuroprotective Effects of the Purine-Derived Compound ITH15004 Against Nigericin- and Mitochondria-Induced Toxicity in NSC-34 Motor Neuron-like Cells

María F. Cano‐Abad, Ricardo de Pascual, Paloma Kênia de Moraes Berenguel Lossavaro, Marta Olazabal et al.
bioRxiv (Cold Spring Harbor Laboratory)
Amyotrophic Lateral Sclerosis Research
preprint

Neuroprotective Effects of the Purine-Derived Compound ITH15004 Against Nigericin- and Mitochondria-Induced Toxicity in NSC-34 Motor Neuron-like Cells

María F. Cano‐Abad, Ricardo de Pascual, Paloma Kênia de Moraes Berenguel Lossavaro, Marta Olazabal, Savannah Ciach
preprint en

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by the progressive degeneration of motor neurons. Most patients die within 3 to 5 years of diagnosis, primarily due to respiratory failure, and effective therapeutic options remain limited. Mitochondrial dysfunction, oxidative stress, calcium dysregulation, and neuroinflammation are key contributors to ALS pathogenesis. In this study, we evaluated the potential neuroprotective effects of ITH15004, a novel compound with modulatory effects on P2X7 purinergic receptors, in an in vitro model using NSC-34 motor neuron-like cells. Cellular stress was induced using oligomycin (10 uM) and rotenone (30 uM), inhibitors of mitochondrial oxidative phosphorylation; nigericin (5 uM), a K+/H+ ionophore that disrupts ionic homeostasis; and extracellular ATP (1 mM), a purinergic receptor agonist. MTT-reducing activity was assessed as an indicator of cellular metabolic activity, while caspase-3/7 activity was measured to evaluate apoptotic responses. Intracellular ATP levels, cytosolic calcium responses, and cytochrome c and VDAC1 protein abundance were also analysed. ITH15004 significantly improved MTT-reducing activity following exposure to ATP, oligomycin/rotenone, and nigericin. In addition, ITH15004 partially restored intracellular ATP levels following nigericin treatment and significantly reduced nigericin-induced caspase-3/7 activation. Western blot analysis further revealed significant changes in cytochrome c and VDAC1 protein levels in response to ITH15004 treatment. These findings indicate that ITH15004 attenuates cellular damage induced by different stressors in NSC-34 cells and modulates several parameters associated with cellular energy status and apoptotic signalling. Further studies are needed to establish its mechanisms of action and assess its therapeutic potential in ALS.

bioRxiv (Cold Spring Harbor Laboratory)
Universidade Federal de Mato Grosso do Sul (BR), Universidad Autónoma de Madrid (ES)
Good health and well-being
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon